Midlands Kidney Network - Benefits of Central Delivery Systems (CDS) for In-Centre Haemodialysis
Waste benefits:
Most units will use a 6L canister per treatment which is not fully utilised,…
Renal replacement therapy has a significant impact on the environment as various natural recourses are consumed, hazardous waste is generated and chemical substances are being used. To address this…
Project completed as part of the South Health Campus, Alberta Health Services Green Team Competition, 2024
Team members
Sean Sloan, BSc, BScPT - Program Facilitator
Tracy Smith, BSW,…
Project completed as part of the South Health Campus, Alberta Health Services Green Team Competition, 2024
Team members
Cassandra Carrier, Quality Improvement Lead RN
Daniela Moreira,…
Created on
19 Sep 2024 •
by
Cassandra Carrier, Quality Improvement Lead RN and Daniela Moreira, Emergency Department Unit Manager
Project completed as part of the South Health Campus, Alberta Health Services Green Team Competition, 2024
Team members
Michelle Shand (Program Manager - Surgical Services)
Rachel Taylor…
In-hospital promotion of the oral route and IV to oral switch (IVOST) are key antimicrobial stewardship (AS) initiatives providing benefits for patients, staff and the environment, including reduced…
Created on
30 Aug 2024 •
by
Rodger R, Robertson A, Thompson E, Downie K, Thompson S, Ray G, Chisholm L, Hillson R
This report from Healthcare Without Harm highlights successful initiatives across Europe where pharmacists are taking the lead in promoting responsible medicine use, reducing pharmaceutical waste, and…
This TOG commentary outlines why the climate and ecological crises should be of particular concern to all those working in women's health, the ways in which our healthcare systems contribute to the…
KitNewCare is a pioneering EU co-funded project to make kidney healthcare more environmentally sustainable. Recognising healthcare’s role in global carbon emissions (5-11%), the project focuses on…
To scale and spread promotion of the oral route in antimicrobials with high oral bioavailability with the aim of reducing collective IV use by 20% by February 2023 at RAH.
Created on
24 Jul 2024 •
by
R Rodger, S Thompson, A Robertson, C Pender, G Ray, L Chisholm